Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2026-02-21 @ 11:35 PM
Study NCT ID:
NCT02639650
Status:
RECRUITING
Last Update Posted:
2022-06-03
First Post:
2015-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
Sponsor:
Weiguo Lv
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2015-12-13
First Submit QC Date:
None
Study First Post Date:
2015-12-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-02
Last Update Post Date:
2022-06-03
Last Update Post Date Type:
ACTUAL